Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A picture of your arteries could be worth a thousand prescriptions

NCT ID NCT01849575

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether showing people images of their own carotid arteries (the main arteries in the neck) can improve how they and their doctors manage heart disease risk. Participants are adults aged 40, 50, or 60 who are already part of a health program in Sweden. Some receive standard care, while others also get a color-coded picture of their artery health and a follow-up call. The goal is to see if this visual information leads to better risk factor control and fewer heart problems over time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pictorial information about carotid ultrasound results
What this could lead to
If it works, this approach could help people understand their heart disease risk better and motivate them to make healthier choices, potentially reducing heart attacks and strokes.
What could go wrong
This is a behavioral intervention, so results depend on whether people actually change their habits. The effect may vary widely between individuals, and long-term benefits are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

3,532 people

The number who actually took part.

Started

Apr 2013

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Participant in the Västerbotten Intervention Programme and * 40 years old and a history of CVD at age \< 60 years among first-degree relative or * 50 years old and at least one of the following six criteria: * a history of CVD at age \< 60 years among first-degree relative, * smoking, * diabetes, * hypertension, * S-LDL-cholesterol ≥4.5 mmol/L, * abdominal obesity or * 60 years old Exclusion Criteria: * Stenosis ≥50% of the carotid lumen

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Reseach Center Umeå University Hospital

    Umeå, Se-90185, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.